openPR Logo
Press release

Next Generation Sequencing Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

09-04-2018 01:16 PM CET | Health & Medicine

Press release from: CMI - Biotechnology Industry

Next Generation Sequencing Market

Next Generation Sequencing Market

Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used in several areas of biological study. NGS technologies help in generating genome-wide sequence data in a couple of days. These technologies are highly parallelized allowing to sequence thousands to millions of molecules at the same time. The main advantage of these platforms is determination of the sequenced data from amplified single DNA fragments, avoiding the need for cloning of DNA fragments.

NGS has large number of applications, enabling rapid technological advances across several fields in biological science. The technology has enabled researchers to gain significant knowledge in public health studies and epidemiology, to sequence viruses and bacteria and help detect causes that may contribute to virulence.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/158

Furthermore, in gene expression research, next generation sequencing of RNA replace microarray analysis, allowing researchers to see RNA expression sequence. This RNA sequencing can provide information on entire transcriptome in one analysis, irrespective of any previous knowledge of genetic sequence.

The global next generation sequencing market was valued at US$ 5.6 billion in 2017 and is expected to witness a robust CAGR of 18.1% over the forecast period (2017–2025).

Increasing demand for early detection of cancer and infectious diseases is expected to drive growth of the NGS market

Early detection of cancer and infectious diseases increases the chances of successful treatment. Increasing prevalence of cancer and other infectious diseases is a major factor contributing to growth of the next generation sequencing market. According to the World Health Organization (WHO), in 2012, around 14 million new cases of cancer were reported and the incidence is estimated to increase to 70% by 2030.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/158

Key Vendors of Next Generation Sequencing Market: Thermo Fisher Scientific Inc., Agilent Technologies, Inc., BioMerieux S.A., F. Hoffmann-La Roche Ltd, Qiagen N.V., Illumina, Inc., Oxford Nanopore Technologies, and Beijing Genomics Co. Ltd.

Detailed Segmentation:

Global Next Generation Sequencing Market, By Technology:

Whole Genome Sequencing
Whole Exome Sequencing
RNA Sequencing
Targeted Re-sequencing
Others

Global Next Generation Sequencing Market, By Application:

Drug Discovery
Personalized Medicine and Genetic Screening
Disease Diagnosis
Agriculture and Animal Research
Others

Global Next Generation Sequencing Market, By End User:

Hospital
Research Centers
Pharma and Biotech Firms
Others

Global Next Generation Sequencing Market, By Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Company Profiles

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Sequencing Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here

News-ID: 1218980 • Views: 168

More Releases from CMI - Biotechnology Industry

Global Human Microbiome Market - Merck & Co. Inc., Affymetrix Inc., Vithera Phar …
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Digital Genome Market - Global Industry Insights, Trends, Outlook, and Opportuni …
Digital genome is the complete digital set of genes or genetic material present in a cell or organism. Genome is the branch of biology that deals with the study of genes and their functions. Digital genome allows the conversion of this large volume of data into products and services. A digital genome act as a pivot table that allows instant access to trait combinations to solve seemingly endless custom queries.
Plant Stem Cell Market - Global Industry Insights, Trends, Outlook, and Opportun …
Plant stem cells are undifferentiated cells within the meristems of plants. Plant stem cells serve as the origin of plant vitality as they maintain themselves and provide a steady supply of precursor cells to form various tissues and organs in plants. Plant stem cells are characterized by two distinctive properties namely its ability to create differentiated cell types and to self-renew such that the number of stem cells remain stable.
Artificial Pancreas Device System (APDS) Market - Global Industry Insights, Tren …
Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many industry players such as Medtronic, Inc., Johnson & Johnson, and Tandem

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market
According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global next generation sequencing (NGS) market is expanding at double digit growth rate and is expected to grow at a CAGR of 17% during 2020-2025. Next-generation sequencing refers to the process of determining the sequence of nucleotides in DNA. It involves various procedures, such as sequencing by synthesis (SBS),
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,